دورية أكاديمية

Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study.

التفاصيل البيبلوغرافية
العنوان: Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study.
المؤلفون: Kang, Yoon-Koo, George, Suzanne, Jones, Robin L, Rutkowski, Piotr, Shen, Lin, Mir, Olivier, Patel, Shreyaskumar, Zhou, Yongjian, von Mehren, Margaret, Hohenberger, Peter, Villalobos, Victor, Brahmi, Mehdi, Tap, William D, Trent, Jonathan, Pantaleo, Maria A, Schöffski, Patrick, He, Kevin, Hew, Paggy, Newberry, Kate, Roche, Maria
المصدر: Journal of Clinical Oncology; 10/1/2021, Vol. 39 Issue 28, p3128-3139, 12p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.21.00217